Delisting risk
Ernexa Therapeutics (ERNA)
Develops off-the-shelf engineered iMSC therapies for cancer and autoimmune disease.
$4.54
Pre-market+0.04 (+1.00%)
At close$4.50(+3.33%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions19 holders · as of Mar 31, 2026 | 8.76% | 143.0K shares | |
| Insiders3 holders · as of Aug 27, 2026 | 17.10% | 279.2K shares | |
| Otherremainder | 74.14% | 1.21M shares |
1.63M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (1.63M in the company's Sep 3, 2026 report, 314.1K elsewhere); stakes use the report.
Institutions13F, as of Mar 31, 2026
19 holders · 3.57M shares · 10 new positions · 13 increased · 0 reduced · 5 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Bleichroeder LP | 2.00M | 122.52% | +2.00Mnew | May 14, 2026 |
| Dauntless Investment Group, LLC | 612.4K | 37.52% | +612.4Knew | May 14, 2026 |
| Ci Private Wealth, LLC | 438.1K | 26.84% | +1 | May 15, 2026 |
| Geode Capital Management, LLC | 244.4K | 14.97% | +220.8K | May 15, 2026 |
| XTX Topco Ltd | 54.3K | 3.33% | +54.3Knew | May 15, 2026 |
| Warberg Asset Management LLC | 50.0K | 3.06% | +50.0Knew | May 7, 2026 |
| Jane Street Group, LLC | 41.2K | 2.52% | +41.2Knew | May 12, 2026 |
| Citadel Advisors LLC | 33.1K | 2.03% | +33.1Knew | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Charles Cherington | 37.90% | 13D | Jun 11, 2025 ↗ | |
| Freebird Partners LP | 9.90% | 120.4K | 13G | May 15, 2026 ↗ |
| Shameek Konar | 9.70% | 118.3K | 13G | May 13, 2026 ↗ |
| John D. Halpern | 9.60% | 13G | May 15, 2025 ↗ | |
| Bleichroeder LP | 6.86% | 80.0K | 13G | May 14, 2026 ↗ |
| Iaf, LLC | 5.20% | 13G | May 14, 2025 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Feb 10, 2026 | Charles Cherington10 percent owner | Purchase · 2 lots | 8,000,000 | $0.5900 | 10,779,440 |
CongressHouse and Senate disclosures
Not reported.
